Glycopyrrolate/Formoterol Fumarate Fixed-Dose Combination Delivered by Metered Dose Inhaler Improves Lung Function and Symptoms in Patients with COPD: Results from the PINNACLE-4 Study in Asia, Europe, and the USA

被引：0
|
作者：
Lipworth, B. [1 ]
Collier, D. J. [2 ]
Gon, Y. [3 ]
Zhong, N. [4 ]
Nishi, K. [5 ]
Chen, R. [4 ]
Arora, S. [6 ]
Maes, A. [7 ]
Siddiqui, S. [8 ]
Reisner, C. [7 ]
Martin, U. J. [8 ]
机构：
[1] Univ Dundee, Ninewells Hosp, Scottish Ctr Resp Res, Dundee, Scotland
[2] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England
[3] Nihon Univ, Itabashi Hosp, Sch Med, Itabashi Ku, Tokyo, Japan
[4] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[5] Ishikawa Prefectural Cent Hosp, Kanazawa, Ishikawa, Japan
[6] Aventiv Res Inc, Columbus, OH USA
[7] Pearl Therapeut Inc, Morristown, NJ USA
[8] AstraZeneca, Gaithersburg, MD USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4236
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [41] A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease
    Reisner, Colin
    Fabbri, Leonardo M.
    Kerwin, Edward M.
    Fogarty, Charles
    Spangenthal, Selwyn
    Rabe, Klaus F.
    Ferguson, Gary T.
    Martinez, Fernando J.
    Donohue, James F.
    Darken, Patrick
    St Rose, Earl
    Orevillo, Chad
    Strom, Shannon
    Fischer, Tracy
    Golden, Michael
    Dwivedi, Sarvajna
    RESPIRATORY RESEARCH, 2017, 18
  • [42] Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study
    Ichinose, Masakazu
    Fukushima, Yasushi
    Inoue, Yoshikazu
    Hataji, Osamu
    Ferguson, Gary T.
    Rabe, Klaus F.
    Hayashi, Nobuya
    Okada, Hiroshi
    Takikawa, Mami
    Bourne, Eric
    Ballal, Shaila
    DeAngelis, Kiernan
    Aurivillius, Magnus
    Dorinsky, Paul
    Reisner, Colin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2979 - 2991
  • [43] Safety And Tolerability Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate: Results Of Two 6-Month Studies In Patients With Moderate To Severe COPD
    Make, B. J.
    D'Urzo, A. D.
    Jones, P. W.
    Mergel, V.
    Molins, E.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [44] Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD
    Donohue, James F.
    Soong, Weily
    Wu, Xiao
    Shrestha, Pomy
    Lei, Alejhandra
    RESPIRATORY MEDICINE, 2016, 116 : 41 - 48
  • [45] Cardiovascular Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate: Results Of Two 6-Month Studies In Patients With Moderate To Severe COPD
    Donohue, J. F.
    D'Urzo, A. D.
    Singh, D.
    Mergel, V.
    Molins, E.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [46] Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease
    Colin Reisner
    Leonardo M. Fabbri
    Edward M. Kerwin
    Charles Fogarty
    Selwyn Spangenthal
    Klaus F. Rabe
    Gary T. Ferguson
    Fernando J. Martinez
    James F. Donohue
    Patrick Darken
    Earl St. Rose
    Chad Orevillo
    Shannon Strom
    Tracy Fischer
    Michael Golden
    Sarvajna Dwivedi
    Respiratory Research, 18
  • [47] Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combinations in COPD
    Siddiqui, Mohd Kashif
    Shukla, Pragya
    Jenkins, Martin
    Ouwens, Mario
    Guranlioglu, Deniz
    Darken, Patrick
    Biswas, Mousumi
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [48] Pooled Analyses From Pinnacle-1 And-2: Safety Profile Of The Novel Lama/laba Co-Suspension Technology Fixed-Dose Combination (glycopyrrolate/ formoterol) Delivered By Mdi, In Patients With Chronic Obstructive Pulmonary Disease (COPD)
    Ferguson, G. T.
    Rabe, K. F.
    Martinez, F. J.
    Rodriguez-Roisin, R.
    Fabbri, L. M.
    Jones, P. W.
    Rennard, S. I.
    Siddiqui, S.
    Orevillo, C.
    Darken, P.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [49] Lung function improvements with twice-daily aclidinium/formoterol fixed-dose combination in two 24-week studies in patients with COPD
    Singh, Dave
    D'Urzo, Anthony
    Jones, Paul
    Serra, Cristina
    Mergel, Victor
    Caracta, Cynthia
    Leselbaum, Anne
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [50] FUNCTIONAL RESPIRATORY IMAGING (FRI) AND LUNG FUNCTION ASSESSMENT OF GLYCOPYRRONIUM/FORMOTEROL FUMARATE DIHYDRATE FIXED-DOSE COMBINATION DELIVERED USING INNOVATIVE COSUSPENSION DELIVERY TECHNOLOGY (GFF MDI) IN
    De Backer, W.
    De Backer, J.
    Vos, W.
    Verlinden, I.
    Dwivedi, S.
    Siddiqui, S.
    Jenkins, M.
    Reisner, C.
    Martin, U.
    THORAX, 2017, 72 : A186 - A187
12345